Epinephrine Active Pharmaceutical Ingredient Recalled for Discoloration
Spectrum Laboratory Products is recalling Epinephrine API lot 1KG0865 due to discoloration that may compromise product effectiveness. The product was distributed nationwide in the USA, Puerto Rico, and Canada.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is classified as FDA Class I, the highest classification for drug recalls. While no illnesses or deaths have been reported, the potential for reduced effectiveness of an emergency medication such as epinephrine constitutes a severe public health concern.
Plain-English summary
Spectrum Laboratory Products, Inc. is recalling Epinephrine (L-Adrenaline), USP, in 1 KG amber glass bottles due to discoloration that could result in a less effective product. The affected lot is 1KG0865 with an expiration date of March 31, 2023.
The product was distributed nationwide in the United States, Puerto Rico, and Canada for pharmaceutical use. This is a Class I recall, the FDA's highest classification.
If you have this product, do not use it and contact your healthcare provider or pharmacy for a replacement. Report any adverse events related to this product to the FDA.
The recalled product
- Product
- Epinephrine (L-Adrenaline), USP, CAS 51-43-4, 1 KG amber glass bottle in a vacuum sealed pouch, Rx only, Repackaged by Spectrum Chemical Mfg. Corp. Gardena, CA 90248; New Brunswick, NJ 08901. Product Code EP130
- Manufacturer
- Spectrum Laboratory Products, Inc.
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot # 1KG0865 EXP 31-Mar-2023
Distribution
Part of a larger recall action
This product is one of 2 recalled by Spectrum Laboratory Products, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Spectrum Laboratory Products, Inc.
See all →- SevereEpinephrine API Recalled for Discoloration and Reduced Efficacy
FDA (Drugs) · 2023-02-01
- SevereSpectrum Chemical Recalls Levonorgestrel API Due to CGMP Deviations
FDA (Drugs) · 2017-06-14
- ModerateSpectrum Laboratory Estradiol API Recalled for CGMP Deviations
FDA (Drugs) · 2017-06-14
- SevereSpectrum Chemical Recalls Zinc Acetate Due to Excess Lead Levels
FDA (Drugs) · 2016-08-17
Same hazard · discoloration
See all →- HighICU Medical Recalls IV Sets with Potential Drip Chamber Discoloration
FDA (Devices) · 2026-09-23
- ModerateFresenius Citrasate Liquid Acid Concentrate Recalled for Discoloration
FDA (Devices) · 2026-09-09
- ModerateFresenius NaturaLyte Liquid Acid Concentrate Recalled for Discoloration
FDA (Devices) · 2026-09-09
- ModerateShilpa Medicare Recalls Discolored PEMRYDI RTU Injection Vials
FDA (Drugs) · 2026-08-26
- SevereShilpa Medicare Recalls Discolored Pemetrexed Injection Vials
FDA (Drugs) · 2026-08-26
Similar recalls
- SevereSpectrum Chemical Recalls Levonorgestrel API Due to CGMP Deviations
FDA (Drugs) · 2017-06-14
- HighFDA Recalls Maximum Zone2 Topical Analgesic Due to Epinephrine Discoloration
FDA (Drugs) · 2023-02-22
- HighSpectrum Chemical Recalls Fentanyl Citrate Due to Glass Contamination
FDA (Drugs) · 2019-10-23
- SevereAdrenalin Chloride Epinephrine Nasal Solution Recalled for Misleading Label
FDA (Drugs) · 2025-02-12
- SevereHospira Recalls Epinephrine Injection Due to Potential Glass Particulates
FDA (Drugs) · 2013-01-09
- SevereAvella Recalls Epinephrine Bags Due to Potential Leakage and Sterility Concerns
FDA (Drugs) · 2018-07-25